---
abstract: ''
authors:
- Slawson, David C
category: Clinical Review
clinical_significance: High
cme_credits: 0.0
doi: ''
evidence_level: ''
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36689984/
file_path: 2023/01/pharmacogenomic-testing-for-selection-of-antidepressant-prov.md
issue: '1'
keywords:
- Pharmacogenomic Testing
- Humans
- Antidepressive Agents
- Pharmacogenetics
- Genetic Testing
last_updated: '2025-08-09'
mesh_terms:
- Humans
- Pharmacogenomic Testing
- Antidepressive Agents
- Genetic Testing
- Pharmacogenetics
original_format: PubMed
pages: 97-98
patient_population: Adults
peer_reviewed: true
pmid: '36689984'
processed_date: '2025-08-09'
publication_date: '2023-01-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 1
source: American family physician
specialties:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Pharmacogenomic Testing for Selection of Antidepressant Provides Minimal, If
  Any, Benefit.
topics:
- Family Medicine
volume: '107'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36689984'
  title: Pharmacogenomic Testing for Selection of Antidepressant Provides Minimal,
    If Any, Benefit.
  authors:
  - last_name: Slawson
    fore_name: David C
    initials: DC
    affiliation: Atrium Health, Charlotte, N.C.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '107'
    issue: '1'
  publication_info:
    year: '2023'
    month: '01'
    full_date: '2023-01-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Pharmacogenomic Testing
    major_topic: true
  - descriptor: Antidepressive Agents
    major_topic: true
  - descriptor: Genetic Testing
    major_topic: false
  - descriptor: Pharmacogenetics
    major_topic: false
  publication_types: *id001
related_articles:
- pmid: '36689984'
  title: Pharmacogenomic Testing for Selection of Antidepressant Provides Minimal,
    If Any, Benefit.
  authors:
  - name: Slawson DC
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Jan
- pmid: '38341491'
  title: 'Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic
    testing for antidepressant treatment selection.'
  authors:
  - name: Sun CN
    authtype: Author
    clusterid: ''
  - name: Berenbrok LA
    authtype: Author
    clusterid: ''
  - name: Stevenson JM
    authtype: Author
    clusterid: ''
  source: Neuropsychopharmacology
  pubdate: 2024 Apr
- pmid: '38361000'
  title: 'Reply to Sun: Dynamic and accessible pharmacogenomic results: a response
    to pharmacogenomic testing for antidepressant treatment selection.'
  authors:
  - name: Frye MA
    authtype: Author
    clusterid: ''
  - name: Nemeroff CB
    authtype: Author
    clusterid: ''
  source: Neuropsychopharmacology
  pubdate: 2024 Apr
- pmid: '31584716'
  title: Is Pharmacogenetics Useful in Antidepressant Treatment?
  authors:
  - name: Fabbri C
    authtype: Author
    clusterid: ''
  - name: Serretti A
    authtype: Author
    clusterid: ''
  source: Clin Pharmacol Ther
  pubdate: 2019 Nov
- pmid: '37550439'
  title: 'Pharmacogenomic testing for antidepressant treatment selection: lessons
    learned and roadmap forward.'
  authors:
  - name: Frye MA
    authtype: Author
    clusterid: ''
  - name: Nemeroff CB
    authtype: Author
    clusterid: ''
  source: Neuropsychopharmacology
  pubdate: 2024 Jan
---

# Pharmacogenomic Testing for Selection of Antidepressant Provides Minimal, If Any, Benefit.

**Authors:** Slawson, David C

**Published in:** American family physician | Vol. 107, No. 1 | 2023-01-01

**Links:** [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36689984/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Pharmacogenomic Testing, Antidepressive Agents, Genetic Testing, Pharmacogenetics

## Article Content

# Pharmacogenomic Testing for Selection of Antidepressant Provides Minimal, If Any, Benefit.

**Authors:** Slawson, David C

**Published in:** American family physician | Vol. 107, No. 1 | 2023-01-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36689984/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Pharmacogenomic Testing, Antidepressive Agents, Genetic Testing, Pharmacogenetics

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36689984/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36689984/) (reference)

---

*Processed: 2025-08-09* | *PubMed Enhanced: 2025-07-30*
